Here is how to think about them together
Since retatrutide activates GIP receptors that enhance insulin sensitivity, some researchers theorize that morning injection could synergize with the natural morning insulin sensitivity peak to produce slightly better metabolic outcomes
Jill Health, DooU and Raven Three additional Canadian telehealth services prescribe Ozempic, typically for weight management
The WADA Prohibited List and military policies continue to expand as more synthetic peptides are monitored
The verdict Conditional on most plans Aetna is one of the stronger commercial-coverage stories in the weight-loss GLP-1 space: its pharmacy benefit manager, CVS Caremark, made Wegovy the preferred weight-loss GLP-1 effective July 1, 2025, meaning it is covered with prior authorization on Aetna commercial plans but Aetna's weight-loss-only PA threshold is BMI 35 or higher, stricter than the FDA label (BMI 30 or 27 with a comorbidity)
doi: 10.4140/TCP.n.2016.685 85 Liraglutide: A new option for the treatment of obesity